Foralumab
Foralumab (TZLS-401), being researched by Tiziana Life Sciences ) is a fully human monoclonal antibody that binds to CD3 epsilon of the T cell receptor-CD3 complex.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Foralumab (TZLS-401), being researched by Tiziana Life Sciences ) is a fully human monoclonal antibody that binds to CD3 epsilon of the T cell receptor-CD3 complex. It is currently being studied in a randomized, double-blind placebo-controlled, multicenter dose-ranging study in a nasal formulation in patients with non-active secondary progressive multiple sclerosis (SPMS).
Text derived from https://en.wikipedia.org/w/index.php?oldid=1314089627 under CC BY-SA 4.0; modifications have been made.